Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration.

McGuinness MB, Finger RP, Wu Z, Luu CD, Chen FK, Arnold JJ, Chakravarthy U, Heriot WJ, Runciman J, Guymer RH; LEAD Study Group.

Transl Vis Sci Technol. 2019 Sep 11;8(5):3. doi: 10.1167/tvst.8.5.3. eCollection 2019 Sep.

2.

Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report.

Wu Z, Luu CD, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, Harper CA, Wickremasinghe SS, Sandhu SS, McGuinness MB, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Wintergerst MWM, Gorgi Zadeh S, Schultz T, Finger RP, Cohn AC, Baglin EK, Sharangan P, Guymer RH; LEAD Study Group.

Ophthalmol Retina. 2019 Jul 22. pii: S2468-6530(19)30467-1. doi: 10.1016/j.oret.2019.07.008. [Epub ahead of print]

PMID:
31582304
3.

Performance of a Defect-Mapping Microperimetry Approach for Characterizing Progressive Changes in Deep Scotomas.

Wu Z, Cimetta R, Caruso E, Guymer RH.

Transl Vis Sci Technol. 2019 Aug 1;8(4):16. doi: 10.1167/tvst.8.4.16. eCollection 2019 Jul.

4.

Geographic Atrophy Trials: Turning the Ship around May Not Be That Easy.

Guymer RH.

Ophthalmol Retina. 2018 Jun;2(6):515-517. doi: 10.1016/j.oret.2018.03.004. Epub 2018 Apr 11. No abstract available.

PMID:
31047603
5.

Interpretation of Subretinal Fluid Using OCT in Intermediate Age-Related Macular Degeneration.

Lek JJ, Caruso E, Baglin EK, Sharangan P, Hodgson LAB, Harper CA, Rosenfeld PJ, Luu CD, Guymer RH.

Ophthalmol Retina. 2018 Aug;2(8):792-802. doi: 10.1016/j.oret.2018.01.005. Epub 2018 Mar 16.

PMID:
31047532
6.

Topographic Rod Recovery Profiles after a Prolonged Dark Adaptation in Subjects with Reticular Pseudodrusen.

Luu CD, Tan R, Caruso E, Fletcher EL, Lamb TD, Guymer RH.

Ophthalmol Retina. 2018 Dec;2(12):1206-1217. doi: 10.1016/j.oret.2018.06.016. Epub 2018 Aug 18.

PMID:
31047193
7.

Longitudinal Assessment of Rod Function in Intermediate Age-Related Macular Degeneration With and Without Reticular Pseudodrusen.

Tan RS, Guymer RH, Aung KZ, Caruso E, Luu CD.

Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1511-1518. doi: 10.1167/iovs.18-26385.

PMID:
30994862
8.

Psychosocial assessment of potential retinal prosthesis trial participants.

Bentley SA, O'Hare F, Murphy GC, Finger RP, Luu CD, Keeffe JE, Abbott CJ, Guymer RH, Ayton LN.

Clin Exp Optom. 2019 Sep;102(5):506-512. doi: 10.1111/cxo.12889. Epub 2019 Mar 4.

PMID:
30834589
9.

Living with Geographic Atrophy: An Ethnographic Study.

Sivaprasad S, Tschosik EA, Guymer RH, Kapre A, Suñer IJ, Joussen AM, Lanzetta P, Ferrara D.

Ophthalmol Ther. 2019 Mar;8(1):115-124. doi: 10.1007/s40123-019-0160-3. Epub 2019 Jan 31.

10.

Microperimetry for geographic atrophy secondary to age-related macular degeneration.

Csaky KG, Patel PJ, Sepah YJ, Birch DG, Do DV, Ip MS, Guymer RH, Luu CD, Gune S, Lin H, Ferrara D.

Surv Ophthalmol. 2019 May - Jun;64(3):353-364. doi: 10.1016/j.survophthal.2019.01.014. Epub 2019 Jan 28.

11.

Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.

Gillies MC, Hunyor AP, Arnold JJ, Guymer RH, Wolf S, Ng P, Pecheur FL, McAllister IL.

JAMA Ophthalmol. 2019 Apr 1;137(4):372-379. doi: 10.1001/jamaophthalmol.2018.6776.

12.

Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results.

Guymer RH, Markey CM, McAllister IL, Gillies MC, Hunyor AP, Arnold JJ; FLUID Investigators.

Ophthalmology. 2019 May;126(5):723-734. doi: 10.1016/j.ophtha.2018.11.025. Epub 2018 Nov 29.

PMID:
30502372
13.

Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration.

Adams M, Ho CYD, Baglin E, Sharangan P, Wu Z, Lawson DJ, Luu CD, Turpin A, McKendrick AM, Guymer RH.

Transl Vis Sci Technol. 2018 Oct 29;7(5):32. doi: 10.1167/tvst.7.5.32. eCollection 2018 Sep.

14.

Reticular pseudodrusen: current understanding.

Wightman AJ, Guymer RH.

Clin Exp Optom. 2019 Sep;102(5):455-462. doi: 10.1111/cxo.12842. Epub 2018 Oct 8. Review.

PMID:
30298528
15.

Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial.

Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, McGuinness MB, Fletcher EL, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Lek JJ, Harper CA, Wickremasinghe SS, Sandhu SS, Baglin EK, Sharangan P, Braat S, Luu CD; Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group.

Ophthalmology. 2019 Jun;126(6):829-838. doi: 10.1016/j.ophtha.2018.09.015. Epub 2018 Sep 20. Update in: Ophthalmology. 2019 Jun;126(6):839-840.

16.

Subretinal Drusenoid Deposits and the Loss of Rod Function in Intermediate Age-Related Macular Degeneration.

Tan R, Guymer RH, Luu CD.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4154-4161. doi: 10.1167/iovs.18-23970.

PMID:
30105370
17.

The Treat-and-Extend Injection Regimen Versus Alternate Dosing Strategies in Age-related Macular Degeneration: A Systematic Review and Meta-analysis.

Okada M, Kandasamy R, Chong EW, McGuiness M, Guymer RH.

Am J Ophthalmol. 2018 Aug;192:184-197. doi: 10.1016/j.ajo.2018.05.026. Epub 2018 Jun 6.

PMID:
29885297
18.

Longitudinal Changes in Retinotopic Rod Function in Intermediate Age-Related Macular Degeneration.

Nguyen CT, Fraser RG, Tan R, Caruso E, Lek JJ, Guymer RH, Luu CD.

Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD19-AMD24. doi: 10.1167/iovs.17-23084.

PMID:
29860308
19.

Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration.

Lorés-Motta L, Riaz M, Grunin M, Corominas J, van Asten F, Pauper M, Leenders M, Richardson AJ, Muether P, Cree AJ, Griffiths HL, Pham C, Belanger MC, Meester-Smoor MA, Ali M, Heid IM, Fritsche LG, Chakravarthy U, Gale R, McKibbin M, Inglehearn CF, Schlingemann RO, Omar A, Chen J, Koenekoop RK, Fauser S, Guymer RH, Hoyng CB, de Jong EK, Lotery AJ, Mitchell P, den Hollander AI, Baird PN, Chowers I.

JAMA Ophthalmol. 2018 Aug 1;136(8):875-884. doi: 10.1001/jamaophthalmol.2018.2019.

20.

Relationship between reticular pseudodrusen and choroidal thickness in intermediate age-related macular degeneration: response.

Ho CY, Lek JJ, Aung KZ, McGuinness MB, Luu CD, Guymer RH.

Clin Exp Ophthalmol. 2018 Nov;46(8):967-968. doi: 10.1111/ceo.13317. Epub 2018 May 29. No abstract available.

PMID:
29736968
21.

Repeatability of Retinal Sensitivity Measurements Using a Medmont Dark-Adapted Chromatic Perimeter in Healthy and Age-Related Macular Degeneration Cases.

Tan RS, Guymer RH, Luu CD.

Transl Vis Sci Technol. 2018 May 1;7(3):3. doi: 10.1167/tvst.7.3.3. eCollection 2018 May.

22.

Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family.

Cantsilieris S, Nelson BJ, Huddleston J, Baker C, Harshman L, Penewit K, Munson KM, Sorensen M, Welch AE, Dang V, Grassmann F, Richardson AJ, Guymer RH, Graves-Lindsay TA, Wilson RK, Weber BHF, Baird PN, Allikmets R, Eichler EE.

Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4433-E4442. doi: 10.1073/pnas.1717600115. Epub 2018 Apr 23.

23.

Role of lysophosphatidic acid in the retinal pigment epithelium and photoreceptors.

Lidgerwood GE, Morris AJ, Conquest A, Daniszewski M, Rooney LA, Lim SY, Hernández D, Liang HH, Allen P, Connell PP, Guymer RH, Hewitt AW, Pébay A.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jul;1863(7):750-761. doi: 10.1016/j.bbalip.2018.04.007. Epub 2018 Apr 13.

PMID:
29660533
24.

A Tablet-Based Retinal Function Test in Neovascular Age-Related Macular Degeneration Eyes and At-Risk Fellow Eye.

Ho CYD, Wu Z, Turpin A, Lawson DJ, Luu CD, McKendrick AM, Guymer RH.

Transl Vis Sci Technol. 2018 Mar 1;7(2):2. doi: 10.1167/tvst.7.2.2. eCollection 2018 Mar.

25.

Prophylactic laser in age-related macular degeneration: the past, the present and the future.

Findlay Q, Jobling AI, Vessey KA, Greferath U, Phipps JA, Guymer RH, Fletcher EL.

Eye (Lond). 2018 May;32(5):972-980. doi: 10.1038/s41433-018-0035-1. Epub 2018 Mar 9. Review.

26.

Nanosecond Laser Treatment for Age-Related Macular Degeneration Does Not Induce Focal Vision Loss or New Vessel Growth in the Retina.

Vessey KA, Ho T, Jobling AI, Mills SA, Tran MX, Brandli A, Lam J, Guymer RH, Fletcher EL.

Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):731-745. doi: 10.1167/iovs.17-23098.

PMID:
29392319
27.

Splitting the Lumps: The Importance of Phenotyping Drusen.

Guymer RH.

Ophthalmology. 2018 Jan;125(1):6-7. doi: 10.1016/j.ophtha.2017.09.007. No abstract available.

PMID:
29268869
28.

Relationship between reticular pseudodrusen and choroidal thickness in intermediate age-related macular degeneration.

Ho CY, Lek JJ, Aung KZ, McGuinness MB, Luu CD, Guymer RH.

Clin Exp Ophthalmol. 2018 Jul;46(5):485-494. doi: 10.1111/ceo.13131. Epub 2018 Jan 11.

PMID:
29236343
29.

Imaging Lenticular Autofluorescence in Older Subjects.

Charng J, Tan R, Luu CD, Sadigh S, Stambolian D, Guymer RH, Jacobson SG, Cideciyan AV.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):4940-4947. doi: 10.1167/iovs.17-22540.

30.

Drusen in patient-derived hiPSC-RPE models of macular dystrophies.

Galloway CA, Dalvi S, Hung SSC, MacDonald LA, Latchney LR, Wong RCB, Guymer RH, Mackey DA, Williams DS, Chung MM, Gamm DM, Pébay A, Hewitt AW, Singh R.

Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8214-E8223. doi: 10.1073/pnas.1710430114. Epub 2017 Sep 6.

31.
32.

Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study.

McGuinness MB, Finger RP, Karahalios A, Guymer RH, English DR, Chong EW, Hodge AM, Robman LD, Giles GG, Simpson JA; Medscape.

Eye (Lond). 2017 Sep;31(9):1345-1357. doi: 10.1038/eye.2017.139. Epub 2017 Aug 18.

33.

Automatic segmentation of nine retinal layer boundaries in OCT images of non-exudative AMD patients using deep learning and graph search.

Fang L, Cunefare D, Wang C, Guymer RH, Li S, Farsiu S.

Biomed Opt Express. 2017 Apr 27;8(5):2732-2744. doi: 10.1364/BOE.8.002732. eCollection 2017 May 1.

34.

Determining the Contribution of Retinotopic Discrimination to Localization Performance With a Suprachoroidal Retinal Prosthesis.

Petoe MA, McCarthy CD, Shivdasani MN, Sinclair NC, Scott AF, Ayton LN, Barnes NM, Guymer RH, Allen PJ, Blamey PJ; Bionic Vision Australia Consortium.

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3231-3239. doi: 10.1167/iovs.16-21041.

PMID:
28660276
35.

Loss of Function of P2X7 Receptor Scavenger Activity in Aging Mice: A Novel Model for Investigating the Early Pathogenesis of Age-Related Macular Degeneration.

Vessey KA, Gu BJ, Jobling AI, Phipps JA, Greferath U, Tran MX, Dixon MA, Baird PN, Guymer RH, Wiley JS, Fletcher EL.

Am J Pathol. 2017 Aug;187(8):1670-1685. doi: 10.1016/j.ajpath.2017.04.016. Epub 2017 Jun 17.

PMID:
28628761
36.

Physical Activity and Age-related Macular Degeneration: A Systematic Literature Review and Meta-analysis.

McGuinness MB, Le J, Mitchell P, Gopinath B, Cerin E, Saksens NTM, Schick T, Hoyng CB, Guymer RH, Finger RP.

Am J Ophthalmol. 2017 Aug;180:29-38. doi: 10.1016/j.ajo.2017.05.016. Epub 2017 May 24. Review.

PMID:
28549846
37.

Progress in the clinical development and utilization of vision prostheses: an update.

Brandli A, Luu CD, Guymer RH, Ayton LN.

Eye Brain. 2016 May 11;8:15-25. doi: 10.2147/EB.S70822. eCollection 2016. Review.

38.

Quantitative Analysis of the Ellipsoid Zone Intensity in Phenotypic Variations of Intermediate Age-Related Macular Degeneration.

Gin TJ, Wu Z, Chew SK, Guymer RH, Luu CD.

Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2079-2086. doi: 10.1167/iovs.16-20105.

PMID:
28388704
39.

Survival Bias When Assessing Risk Factors for Age-Related Macular Degeneration: A Tutorial with Application to the Exposure of Smoking.

McGuinness MB, Karahalios A, Kasza J, Guymer RH, Finger RP, Simpson JA.

Ophthalmic Epidemiol. 2017 Aug;24(4):229-238. doi: 10.1080/09286586.2016.1276934. Epub 2017 Mar 13.

PMID:
28287849
40.

Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration.

Krilis M, Qi M, Madigan MC, Wong JWH, Abdelatti M, Guymer RH, Whitelock J, McCluskey P, Zhang P, Qi J, Hunyor AP, Krilis SA, Giannakopoulos B.

Oncotarget. 2017 Jul 25;8(30):49016-49032. doi: 10.18632/oncotarget.14940.

41.

Age-Related Macular Degeneration and Mortality: A Systematic Review and Meta-Analysis.

McGuinness MB, Karahalios A, Finger RP, Guymer RH, Simpson JA.

Ophthalmic Epidemiol. 2017 Jun;24(3):141-152. doi: 10.1080/09286586.2016.1259422. Epub 2017 Jan 31. Review.

PMID:
28139151
42.

Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1).

Lek JJ, Brassington KH, Luu CD, Chen FK, Arnold JJ, Heriot WJ, Durkin SR, Chakravarthy U, Guymer RH; Laser in Early Stages of Age-Related Macular Degeneration Study Writing Committee.

Ophthalmol Retina. 2017 May - Jun;1(3):227-239. doi: 10.1016/j.oret.2016.12.001. Epub 2017 Jan 31.

PMID:
31047426
43.

GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration.

Riaz M, Lorés-Motta L, Richardson AJ, Lu Y, Montgomery G, Omar A, Koenekoop RK, Chen J, Muether P, Altay L, Schick T, Fauser S, Smailhodzic D, van Asten F, de Jong EK, Hoyng CB, Burdon KP, MacGregor S, Guymer RH, den Hollander AI, Baird PN.

Sci Rep. 2016 Nov 28;6:37924. doi: 10.1038/srep37924.

44.

Automatic Identification of Pathology-Distorted Retinal Layer Boundaries Using SD-OCT Imaging.

Hussain MA, Bhuiyan A, Turpin A, Luu CD, Smith RT, Guymer RH, Kotagiri R.

IEEE Trans Biomed Eng. 2017 Jul;64(7):1638-1649. doi: 10.1109/TBME.2016.2619120. Epub 2016 Oct 19.

PMID:
27775509
45.

Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration.

Essex RW, Nguyen V, Walton R, Arnold JJ, McAllister IL, Guymer RH, Morlet N, Young S, Barthelmes D, Gillies MC; Fight Retinal Blindness Study Group.

Ophthalmology. 2016 Nov;123(11):2393-2400. doi: 10.1016/j.ophtha.2016.07.012. Epub 2016 Aug 20. Erratum in: Ophthalmology. 2017 May;124(5):746.

PMID:
27554034
46.

Assessment of Retinotopic Rod Photoreceptor Function Using a Dark-Adapted Chromatic Perimeter in Intermediate Age-Related Macular Degeneration.

Fraser RG, Tan R, Ayton LN, Caruso E, Guymer RH, Luu CD.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5436-5442. doi: 10.1167/iovs.16-19295.

PMID:
27756079
47.

Stimulation of a Suprachoroidal Retinal Prosthesis Drives Cortical Responses in a Feline Model of Retinal Degeneration.

Aplin FP, Fletcher EL, Luu CD, Vessey KA, Allen PJ, Guymer RH, Shepherd RK, Shivdasani MN.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5216-5229. doi: 10.1167/iovs.16-19926.

PMID:
27701633
48.

Disparities in access to anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration.

Finger RP, Xie J, Fotis K, Parikh S, Cummins R, Mitchell P, Guymer RH.

Clin Exp Ophthalmol. 2017 Mar;45(2):143-151. doi: 10.1111/ceo.12804. Epub 2016 Sep 12.

PMID:
27449314
49.

Longitudinal Associations Between Microstructural Changes and Microperimetry in the Early Stages of Age-Related Macular Degeneration.

Wu Z, Cunefare D, Chiu E, Luu CD, Ayton LN, Toth CA, Farsiu S, Guymer RH.

Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3714-22. doi: 10.1167/iovs.15-18294.

PMID:
27415789
50.

Advances in implantable bionic devices for blindness: a review.

Lewis PM, Ayton LN, Guymer RH, Lowery AJ, Blamey PJ, Allen PJ, Luu CD, Rosenfeld JV.

ANZ J Surg. 2016 Sep;86(9):654-9. doi: 10.1111/ans.13616. Epub 2016 Jun 14. Review.

Supplemental Content

Loading ...
Support Center